| CEO: | Richard Compton |
| CFO & Executive Director: | Paul Stockdale |
| Chief Scientific Officer: | Alexandre Akoulitchev |
| Independent Non-Executive Director: | David Holbrook |
| Non-Executive Chairman: | Iain Ross |
| Non-Executive Dir: | Peter Presland, Martin Diggle |
| Address: | 3140 Rowan Place, John Smith Drive, Oxford Business Park South, Oxford, United Kingdom, OX4 2WB |
| Phone: | +44 (0)1865 518 910 |
| Website: | http://www.oxfordbiodynamics.com/ |
| Index: | FTSE AIM All-Share |
| ISIN: | GB00BD5H8572 |
| Currency | UK Pounds |
| Share Price | 0.12p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 0.59p |
| 52 Week Low | 0.090p |
| Volume | 12,731,345 |
| Shares Issued | 13,441m |
| Market Cap | £15.46m |
| Beta | 0.01 |
| Value | ![]() |
|---|
| Price Trend | ![]() |
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:13 | 2,582,801 @ 0.12p |
| 16:00 | 269 @ 0.12p |
| 14:27 | 4,000 @ 0.12p |
| 14:26 | 83,402 @ 0.12p |
| 14:26 | 63,250 @ 0.12p |
You are here: research